MIRA
INFORM REPORT
|
Report Date : |
11.08.2008 |
IDENTIFICATION
DETAILS
|
Correct Name : |
KIL POONG C & PHARM CO., LTD. |
|
|
|
|
Registered Office : |
3rd Fl., Jeongsong Bldg. 954-7, Siheung 3-dong, Geumcheon-gu, Seoul 153-861 |
|
|
|
|
Country : |
Korea |
|
|
|
|
Financial as on : |
31.12.2006 |
|
|
|
|
Date of Incorporation : |
05.14.1998 |
|
|
|
|
Com. Reg. No.: |
119-81-27864 |
|
|
|
|
Legal Form : |
Company Limited by Shares |
|
|
|
|
Line of Business : |
Wholesale of Other Chemical Materials and Chemical Products |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
Basic
|
Company
Name |
KIL POONG C & PHARM CO., LTD. |
|
Registered Address |
954-7, Siheung 3-dong, Geumcheon-gu,
Seoul, Korea |
|
Building |
3rd Fl., Jeongsong Bldg. |
|
Zip Code |
153-861 |
|
Tel |
+82-2-809-3472 |
|
Fax |
+82-2-894-6936 |
|
E-mail |
dong4696@yahoo.co.kr;kilpoong@unitel.co.kr |
|
Trading Address |
3rd Fl., Jeongsong Bldg., 954-7, Siheung
3-dong, Geumcheon-gu, Seoul, Korea |
|
Tel |
+82-2-809-3472 |
|
Fax |
+82-2-894-6936 |
|
Type |
Export/Import |
|
Industry |
Wholesale of Other Chemical Materials and Chemical Products |
|
Main Business |
Chemicals, Drugs & Pharmaceutical Products, Pharmaceutical Raw
Materials |
|
Sub Business |
Wholesale of Pharmaceuticals |
|
Established (mm/dd/yyyy) |
05/14/1998 |
The Subject
occupies the premises of registered HQ address by leasing base.
Detailed Products
|
Activity |
Detailed Products (UNSPSC) |
|
Sell |
Chemicals |
|
Sell |
Drugs & Pharmaceutical Products |
|
Sell |
Pharmaceutical Raw Materials |
CEO’s
|
Name |
Nam Jong-Hoon |
|
Address |
726, Seongbok-dong, Suji-gu, Yongin-si, Gyeonggi-do,
Korea |
|
Date of Birth |
07/30/1960 |
|
Title |
President & CEO |
|
Sex |
Male |
|
Nationality |
Korean |
Mr. Nam Jong-Hoon has
been graduated from Kyungnam University, Korea.
Profiles
|
Capital |
200,000,000 KRW |
|
Employees |
6 |
|
Formation |
Co., Ltd by shares |
|
Bank Details |
Shinhan Bank-Shihung Nam Branch |
|
Corporate Registered No. |
110111-1545908 |
|
Business Registered No. |
119-81-27864 |
|
Permit & Licenses |
Int’l Trade No.: 11530299 |
|
Shareholder Position |
N/A |
|
Company History |
05/14/1998 Incorporated as RICH CHEM CO.,
LTD. 12/30/1999 Changed company Name to KIL
POONG Chemical Co., Ltd. 05/15/2001 Moved to the present HQ address
from 984, Siheung 3-dong, Geumcheon-gu, Seoul, Korea 12/23/2001 Increased capital to 100,000,000
KRW from 50,000,000 KRW 04/01/2005 Increased capital to
200,000,000 KRW from 100,000,000 KRW 03/21/2008 Changed company name to the
present name |
|
|
|
Management
|
Job Description |
Title |
Name |
Sex |
Nationality |
Inauguration Day |
|
President & CEO |
Mr. |
Nam Jong-Hoon |
Male |
Korean |
03/21/2008 |
|
Director |
Mr. |
Park Sung-Kyu |
Male |
Korean |
03/24/2008 |
|
Auditor |
Mr. |
Cha Young-Kwon |
Male |
Korean |
05/14/1998 |
Financials
Unit: KRW
|
Year |
Sales |
Assets |
Net income |
|
|
|
|
|
|
2006 |
16,644,000,000 |
4,510,000,000 |
264,000,000 |
|
2005 |
12,262,000,000 |
3,981,000,000 |
225,000,000 |
|
2004 |
11,946,000,000 |
3,608,000,000 |
214,000,000 |
Financial Description
Unit: KRW
|
Authorized
Capital |
200,000,000 |
|
Paid-Up
Capital |
200,000,000 |
|
Total Issues Shares |
20,000 |
Balance
Sheet
|
Unit : Million Korean Won |
As of 12/31/2006 |
As of 12/31/2005 |
As of 12/31/2004 |
|
Total Assets |
4,510 |
3,981 |
3,608 |
|
Current Assets |
4,447 |
3,909 |
3,547 |
|
-Quick Assets |
3,769 |
3,909 |
3,258 |
|
-Inventories |
678 |
- |
290 |
|
Fixed Assets |
63 |
72 |
60 |
|
-Investment |
40 |
- |
16 |
|
-Tangibles |
14 |
72 |
35 |
|
-Intangibles |
9 |
- |
9 |
|
Total Liabilities |
2,431 |
2,166 |
2,117 |
|
Current Liabilities |
2,431 |
2,166 |
2,117 |
|
Fixed Liabilities |
|
|
|
|
Capital Stock |
200 |
200 |
100 |
|
Capital Surplus |
|
|
|
|
Profit Surplus |
1,881 |
1,616 |
1,392 |
|
Capital Adjustment |
(-)2 |
(-)1 |
(-)1 |
|
Total Equity |
2,079 |
1,815 |
1,491 |
|
Liab. &
Shareholder’s Equity |
4,510 |
3,981 |
3,608 |
Income
Statement
|
Unit : Million Korean Won |
As of 12/31/2006 |
As of 12/31/2005 |
As of 12/31/2004 |
|
Sales |
16,644 |
12,262 |
11,946 |
|
Cost of Sold Goods |
15,150 |
10,935 |
10,642 |
|
Gross Profit |
1,494 |
1,327 |
1,304 |
|
Selling & Admin. Expenses |
1,017 |
924 |
872 |
|
Operating Income |
477 |
403 |
431 |
|
Non-Operating Income |
5 |
18 |
35 |
|
Non-Operating expenses |
191 |
169 |
214 |
|
Ordinary Income |
291 |
252 |
253 |
|
Special Income |
- |
- |
- |
|
Income Before Taxes |
291 |
252 |
253 |
|
Income Taxes Expenses |
27 |
27 |
39 |
|
Net Income |
264 |
225 |
214 |
Sales by
Region (Activity &
Markets)
The Subject deals with the companies in China, India and SA.
Court
Action
Not Available.
News
Clipping
--
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.42.20 |
|
UK Pound |
1 |
Rs.81.48 |
|
Euro |
1 |
Rs.64.27 |
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)